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ABSTRACT
A wide variety of silver-impregnated wound dressings has become available in recent years. This has given the
practitioner choice but little evidence by which an appropriate dressing may be selected. In many instances, the
ancillary function(s) of the dressing will become differentiating factors that influence choice. For example, the
dressing capacity to manage exudate, maintain an optimum moist environment, reduce or avoid maceration,
maintain an intimate contact with the wound bed, promote autolytic debridement, sequester bacteria and bind
matrix metallo proteases (MMPs) are some of those functions that are of clinical significance and may dictate
choice. In this article we present the evidence for these functions, thereby enabling practitioners to evaluate
comparative dressing attributes, and so make an informed choice of which silver dressing best suits the needs of
the wound under differing circumstances.
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INTRODUCTION
The use of silver in medicine has an extensive
history (1) but the incorporation of silver into
Key Points
• the incorporation of silver into
wound dressings is a contem-
porary development that has
initiated a revolution in the
management of local wound
infection
• modern silver dressings run
the risk of being viewed by
the uninformed as no more
than a combination of two
technologies–the dressing with
added silver
wound dressings is a contemporary develop-
ment that has initiated a revolution in the man-
agement of local wound infection. It is inter-
esting to note that the use of topical antisep-
tics came under severe criticism in 1980s and
1990s (2) with the main target being those anti-
septics that were identified as cytotoxic in vitro
not only to micro-organisms but to the host’s
own cells (3). However, history has taught us
that caution should always be exercised when
translating in vitro findings to the in vivo
situation. More recently, clinical concerns asso-
ciated with the use of silver dressings in wound
care have been explored and discussed (4).
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Modern silver dressings run the risk of being
viewed by the uninformed as no more than a
combination of two technologies – the dressing
with added silver. This sometimes leads to a
misdirected emphasis being placed on issues
such as bacterial time to kill and kill rate
thereby implying that there is an enhancement
of dressing performance in terms of clinical
safety and antimicrobial efficacy. Such issues
are of dubious clinical significance and run
the risk of appearing no more than marketing
exercises, intended to influence choice. This
approach, in turn, ignores the intrinsic value
of the carrier dressing suggesting that it is no
more than a passive delivery vehicle for sil-
ver and disregards the contribution that the
dressing itself can make to a successful clinical
outcome.
One of the most significant statements
focussing on silver dressings has been made
recently by Mooney et al. (5). Their opinion
can be summarised as follows:
• Silver broad spectrum antimicrobial
efficacy is not in dispute.
396 © 2009 The Authors. Journal Compilation © 2009 Blackwell Publishing Ltd and Medicalhelplines.com Inc • International Wound Journal • Vol 6 No 5
Topical silver-impregnated dressings
• Choice of dressing rests on
– characteristics of the carrier
dressing;
– delivery kinetics of silver to the
wound;
– the needs of the wound at any
given time.
Viewing all silver dressings from the sole
perspective that they are no more than
dressings with added silver relegates the dressing
component to that of a simple vehicle for the
delivery of silver. It is, therefore, now necessary
to look beyond the mere delivery of the topical
agent and its antimicrobial impact and examine
the contribution that the carrier dressing has to
make to the progress of the wound. That is,
what does the dressing do that impacts on the
factors that inhibit healing?
HOW THE DRESSING TECHNOLOGY
CAN ASSIST IN MANAGING PAIN
Pain is a known impediment to healing
that produces physiological stress (6). The
changing of a wound dressing is recognised as
a time when pain is most likely to occur (7).
Preventing wound trauma and pain were
identified as the two main considerations at
dressing change highlighted via a survey of
nearly 4000 clinicians using a multiple choice
questionnaire (7). It is therefore important to
use tactics that avoid/minimise trauma to the
wound/peri-wound skin and the occurrence
of what Krasner (8) has called cyclic acute
wound pain. Wound dressing technology has
an important role to play if it can avoid those
factors that are considered as contributing
to pain at dressing change. The three most
important factors identified by Moffatt et al. (7)
are dried out dressings, products that adhere
and adhesive dressings. There are limited
clinical studies that focus on the relationship
of wound pain and the dressing material.
Pain occurring at dressing change, that is
operational pain, has received increasing atten-
tion in recent years. Two influential publica-
tions have focussed on pain associated with
dressing related procedures: the World Union
of Wound Healing Societies’ Principles of
best practice (9) and European Wound Man-
agement Association’s Position document (10).
These publications propose broad strategies to
assist in minimising pain at dressing change
[reviewed by White and Harding (11)]. A third
publication by Thomas (12) proposed that the
term ‘atraumatic dressing’ could be used to Key Points
• viewing all silver dressings from
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describe those products that are proven to
avoid causing trauma to the wound bed or
peri-wound skin on removal, and included a
review of the literature focussing on soft sil-
icone dressings. Soft silicone dressings until
very recently have not been available in topical
antimicrobial form, nevertheless the atrau-
matic dressing performance characteristic is
important (13).
In a randomised study comparing a silver
polyethylene mesh dressing with 0.5% silver
nitrate solution, Tredget et al. (14) found that
on dressing removal, patients reported wound
pain was lower with the silver polyethylene
mesh than on removal of the silver nitrate
solution. However, patients also reported that
the pain was comparable during application
and 2 hours following application of either
dressing. Therefore, in the short term there
appears to be little merit in using this dressing
approach.
In an open, prospective, randomised, con-
trolled, multicentre study, a total of 131
leg ulcer patients were recruited and ran-
domised to hydrofibre or to alginate dressing
groups (15). Ease of application was rated
‘excellent’ by 76% in the hydrofibre group
compared with 55% in the alginate group
(P = 0.03). More importantly, ease of removal
was rated as excellent by 51% of the hydrofi-
bre group compared with 24% of the alginate
group (P = 0.006). No pain at dressing removal
was experienced by 82% of the hydrofibre
group compared with 62% in the alginate
group (P < 0.001). Less adhesion (P < 0.001)
and less residue (P < 0.001) were also reported
in the hydrofibre group thus minimising
trauma to the wound bed. Moffatt et al. (7)
stated that products such as hydrofibres, algi-
nates amongst others are least likely to cause
pain. In the above study it can be seen that
hydrofibre outperformed alginate according to
the identified parameters.
In a randomised acute/surgical wound
study in 100 patients, hydrofibre performance
was compared with that of alginate (16).
Ninety-two per cent of patients randomised
to the hydrofibre dressing were found to expe-
rience less pain (mild or none) compared with
those who received alginate dressings 80%.
Similarly, those patients who were pain free
at week one postoperatively were hydrofibre
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84% compared with alginate 58%. Although
statistical significance was not shown, the
researchers concluded that the hydrofibre
dressing consistently performed better than
the alginate.
A multicentre prospective randomised con-
trolled trial (RCT) (17) reported on the use of
a carboxymethylcellulose dressing containing
ionic silver (AgNaCMC) and 1% silver sul-
phadiazine (SSD) cream impregnated gauze
in the management of partial-thickness burns
(n = 84). The authors reported less pain dur-
ing dressing change and less burning/stinging
during wear time (up to 21 days) with the
AgNaCMC together with a decreased demand
for procedural and narcotic analgesia.
Fifty patients with partial-thickness burns
were randomised into two equal groups who
received either 1% SSD or a silver-coated,
high-density polyethylene mesh dressing (Ag
polyethylene mesh) (18). Treatments consisted
of either dry gauze dressing with 1% SSD
changed twice daily or dry gauze moistened
with sterile water and application of an Ag
polyethylene mesh with the gauze being
moistened twice daily and the outer Ag
polyethylene mesh changed every 3 days. The
conclusions drawn by the authors of this study
were that the Ag polyethylene mesh provided
a less painful alternative to wound care than
1% SSD because of longer wear time and ease
of application/removal (average pain scores
being 4 ± 0.6 for an Ag polyethylene mesh
versus 5 ± 0.7 for 1% SSD).
In an open label, multicentre, non compar-
ative study on 18 patients with chronic leg
ulcers where the primary aim was to assess
safety of an AgNaCMC dressing, Vanscheidt
et al. (19) found that a significant reduction in
the pain scores recorded by the patients was
achieved. It needs to be borne in mind that
11 of the 18 subjects’ wounds were infected at
baseline. At each dressing change the patient
was asked if the dressing had been comfort-
able since the last visit. All 129 responses were
either very comfortable (13.18%) or comfort-
able (86.82%). For pain on dressing removal,
no pain was recorded at 45.7% (59) of dressing
changes with low levels of pain (score  2.5)
being recorded on 33.3% (43) occasions.
Jester et al. (20) recognises the fact that
dressings differ in material characteristics
and evaluated dressing performance and pain
during dressing change of two silver dressings:
a soft polyester with lipido-colloid coating
impregnated with SSD (polyester LC SSD) and
a non adhesive polyurethane foam dressing
impregnated with silver (polyurethane foam
Ag). This retrospective cohort study included
two groups of 20 burns treated with polyester
LC SSD and polyurethane foam Ag until the
wounds healed or were grafted. There were
67 dressing changes in the polyester LC SSD
group and 70 in the polyurethane foam Ag
group. Both dressings were found to perform
well when considering pain at dressing
change and ease at dressing application. The
polyurethane foam Ag dressing was found to
have a greater absorptive capacity than the
polyester LC SSD dressing.
In a prospective, randomised study, Glat
et al. (21) assessed the clinical and microbiolog-
ical characteristics of two silver-based topical
agents in the management of paediatric partial-
thickness burns. Twenty-four patients ranging
in age from 2 months to 18 years with total
body surface area (TBSA) burns ranging from
1% up to 40% were enrolled and completed
the study. Patients were randomised to either
a silver-containing gel or to a SSD cream for up
to 21 days or to the point of full reepithelialisa-
tion of the wound. No statistically significant
differences were found when assessing the rate
of infection, time to reepithelialisation, or the
number of dressings changes required during
treatment. A reduction of pain and improved
patient satisfaction with the use of the gel indi-
cates an important role for it in the treatment
of partial-thickness burns.
THE VALUE OF CLOSE
ASSOCIATION OF DRESSING
WITH THE WOUND BED
Snyder (22) has recorded that the presence of
dead space may act as a nidus for infection and
contribute to delayed healing. Robson et al.
(1973) cited by Edberg (23) states that dead
space lends itself to infection because it does
not possess a defence mechanism.
These statements clearly indicate that there
is a need to avoid the creation of dead space
(void within a viscus or between dressing and
wound bed) as there is an apparent association
of dead space with risk of infection.
In order to circumvent this situation when
applying a wound dressing, the clinician
should ensure that the dressing has the
capacity to maintain a close association with
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the wound bed. It is also reasonable to assume
that in those dressings with an absorptive
capacity, a close association of the dressing
with the wound bed will help promote
absorption of exudate and the delivery of
silver to the wound bed in silver-containing
dressings. Vanscheidt et al. (19) made an
empirical observation in their study on 18
patients with chronic leg ulcers that the gel
matrix formed by the AgNaCMC dressing
moulded itself over the wound surface and
eliminated dead space. This observation was
subsequently confirmed by Jones et al. (24)
who investigated the conformability in vitro of
two silver dressings to human wound tissue,
dried dermal membrane and indented agar
plates that had been seeded with MRSA or
Pseudomonas aeruginosa. The results showed
that there was excellent conformability of
the AgNaCMC dressing to the dermal tissue
(wound bed) but this was less evident with
Ag polyethylene mesh dressing. Incidentally,
the AgNaCMC dressing in this study was more
effective at killing bacteria on the indented agar
plates than the Ag polyethylene mesh dressing.
The intimate association of a dressing with
the irregular undulating topography of the
wound bed would appear to offer advantages
when considering the avoidance of the creation
of dead space, absorption of exudate and





Before the advent of products that incor-
porated antimicrobials, dressings were used
principally from the perspective of material
performance in situ. Up until the 1960s, dress-
ings comprised mainly of woven textiles with
a primarily covering/protective function and
were not regarded as agents capable of enhanc-
ing healing. Following the work of Winter (25),
dressing design took into account the contri-
bution that the dressing material could make
to the reparative process. However, traditional
dressing materials such as gauze continue to
be used despite recognition that it does not
comply with optimal management require-
ments (26). Modern wound dressings have
been developed primarily to afford a moist
wound environment while at the same time
providing an absorptive capacity. If prob-
lems associated with excess moisture at the Key Points
• the intimate association of
a dressing with the irregular
undulating topography of the
wound bed would appear
to offer advantages when
considering the avoidance of
the creation of dead space,
absorption of exudate and
bactericidal activity of ionic
silver
• traditional dressing materials
such as gauze continue to be
used despite recognition that it
does not comply with optimal
management requirements
• modern wound dressings have
been developed primarily to
afford a moist wound envi-
ronment while at the same
time providing an absorptive
capacity
• if problems associated with
excess moisture at the dressing
interface are not managed
correctly, then optimal healing
will be compromised
• in addition to the ancillary
attributes listed above, it has
been claimed that the capacity
of a dressing to absorb and
retain (i.e. sequester) bacte-
ria is an important function,
particularly in chronic wounds
dressing interface are not managed correctly,
then optimal healing will be compromised.
Where absorption of exudate is required, the
dressing should also be capable of retaining
the fluid ensuring at the same time that the
peri-wound skin is not subjected to macera-
tion. Parsons et al. (27) in an in vitro study
investigated the clinical performance of seven
proprietary silver-containing dressings includ-
ing fluid-handling properties and dressing
pH. The findings show that the best fluid
retention under compression was achieved
by AgNaCMC and a silver-containing algi-
nate dressing (Ag alginate) with the lowest
level of lateral wicking occurring with the
AgNaCMC dressing. This paper also states,
‘This study suggests that dressing selection
should be based on the overall properties of
the dressing clinically relevant to the wound
type and condition’.
SEQUESTRATION
In addition to the ancillary attributes listed
above, it has been claimed that the capacity of
a dressing to absorb and retain (i.e. sequester)
bacteria is an important function, particularly
in chronic wounds (28). In vitro and animal in
vivo microbiological studies have illustrated
the extent of this effect in hydrofibre and
alginate dressings (29–32). Whilst the clinical
significance of this feature is yet to be shown,
it is likely to be of value in reducing bioburden
in colonised wounds where antimicrobials
are not indicated, that is routine use in
chronic wounds. This would not contribute
to selection for resistance as the function
is purely physical. A similar function has
been described for the binding of bacterial
toxins (33). In this context, a silver dressing
containing activated charcoal has been shown
to adsorb endotoxins from Escherichia coli and
P. aeruginosa in a standard assay. Although
this too has yet to be shown clinically, it is
an important mechanism for neutralising an
important virulence determinant.
The physical principle of hydrophobic
interaction has been utilised to sequester
bacteria through the addition of a hydrophobic
coating containing a fatty acid derivative
(dialkylcarbamoyl chloride) to the dressing
fibres. Bacteria and other micro-organisms are
‘bound’ to the dressing when in contact with a
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moist environment. The micro-organisms are
then removed when the dressing is changed.Key Points
• although inflammation is a
necessary process, excessive
or prolonged inflammation
results in delayed healing and
increased scarring
• solely considering antimicro-
bial activity as a measure
of dressing performance views
product efficacy from a too nar-
row perspective
• clinicians cannot afford to
ignore the ancillary activity
of the dressing if patients
are to receive optimal and
comprehensive care
In a 116 patient multicentre study with a mean
treatment period of 37 days, 81% of wounds
showing signs of infection at the start of
the treatment healed. Twenty-one per cent of
patients’ wounds healed with a further 72%
showing improvement in wound healing (32).
Hydrophobic interaction would appear to
offer a ‘natural’ approach to wound healing.
There are no chemically active agents and no
known side effects or risk of bacterial/fungal
resistance.
CONTROLLED SUSTAINED RELEASE
It is generally recognised that for any antimi-
crobial to be effective, it is important that the
target organisms be exposed to a cidal con-
centration for sufficient time – without tissue
toxicity (33). This applies to silver-containing
wound dressings, the characteristics of the
‘ideal’ silver-containing dressing having been
published (34). The antibacterial activity of sil-
ver emanates from the ionic form Ag+; this
has been studied extensively in vitro and
reviewed (35). Whilst there is still very little
published information on silver in controlling
wound bioburden, it is possible to state that
sustained exposure (over 24 hours or more) to
very low levels (parts per million) will be effec-
tive against a wide range of bacterial species
including those with known antibiotic resis-
tance, for example MRSA and Vancomycin
resistant enterococci (VRE) (12,24,35–37).
It is pertinent to emphasise at this point the
fact that publications reporting on aqueous
silver concentrations do not differentiate
between active ionic silver (Ag+) and inactive
silver in solution (Ag0); they only measure
total silver content (26). Parsons et al.’s (26)
in vitro findings also clearly inform us that
the antimicrobial activity of any dressing is
not necessarily dependant on the amount of
silver released as ‘there appears to be no
correlation between total silver in solution and
antimicrobial efficacy’.
This accentuates our earlier statement that
the ancillary function of dressings containing
silver should be taken into account and
draws attention to the physical components
of dressings and the role they have to play in
promoting healing (38).
Silver has been used prophylactically and
silver-coated metallic dressings have been
found in vitro to be effective against fungi,
bacteria and multiresistant bacteria (39–41).
Atiyeh et al. (42) confirm that this form of silver
dressing may be useful in preventing infection
and also indicate that silver-coated metallic
dressings provide a high concentration of sil-
ver (around 70 ppm) in the wound by releasing
Ag+ and Ag0. What is not clear is the propor-
tion of Ag+ and Ag0 present in the wound and
the value of such a high concentration if silver
is accepted as being bactericidal/bacteriostatic
at oligodynamic concentrations. Although Ag0
(metallic silver) may oxidise to Ag+ in con-
tact with the atmosphere, there is no evidence
that it is antimicrobial in action. However,
Atiyeh et al. (42) do suggest that the disso-
lution of silver may favour antimicrobial and
anti-inflammatory activity.
MODULATION OF INFLAMMATION
Inflammation is an early and vital stage of
the reparative process and is mediated by a
number of cells (43). Although inflammation
is a necessary process, excessive or prolonged
inflammation results in delayed healing and
increased scarring. In a study using a rat
wound model, Hoekstra et al. (43) made a his-
tological comparison of acute inflammatory
responses in partial-thickness wounds when
using a hydrofibre or tulle gauze dressing. The
findings show that there was minimal inflam-
mation in the hydrofibre dressed wounds
when compared with the Tulle gauze dressed
wounds. This difference was attributed to
the formation of a thin fibrin polymerised
layer between the hydrofibre dressing and
the wound bed. This layer of fibrin clearly
separated the Polymorphonucleocytes (PMNs)
within the hydrofibre dressing from the
macrophages that invaded the wound bed
3–4 days after wounding. Fewer macrophages
were evident in the wound bed and none were
detected in the dressing. Macrophages sepa-
rated from granulocytes act in the repair mode
and are not activated for defence purposes.
This phenomenon of reduction of inflamma-
tion is termed ‘quiet inflammation’. In the
wounds dressed with Tulle gauze, material
was found embedded in the wound bed
which showed ‘a disturbed pattern of epithe-
lial outgrowth’ and ‘damage to the dermal
matrix’.
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CONCLUSIONS
It can be seen from the above discussion
that solely considering antimicrobial activity
as a measure of dressing performance views
product efficacy from a too narrow perspective.
Clinicians cannot afford to ignore the ancillary
activity of the dressing if patients are to receive
optimal and comprehensive care.
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